Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Endocrinology"
DOI: 10.3389/fendo.2022.1041061
Abstract: Background Camurati-Engelmann disease (CED) is a sclerosing bone dysplasia caused by transforming growth factor β1 (TGFB1) gene variants. Objective We aim to summarize the clinical characteristics and the efficacy of glucocorticoids in 14 individuals with…
read more here.
Keywords:
rs1800470;
esr hscrp;
engelmann disease;
camurati engelmann ... See more keywords